Back
Creative Realities Vs. Royalty Pharma PLC Industry Stock Comparison
Sell
47
CREX
Creative Realities
Last Price:
$1.92
Seasonality Move:
14.35%
Sell
28
RPRX
Royalty Pharma PLC
Last Price:
$31.65
Seasonality Move:
-2.74%
Sell
47
Creative Realities (CREX)
is a Sell
Is Creative Realities a Buy, Sell or Hold?
-
The current Creative Realities [CREX] share price is $2.04. The Score for CREX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
CREX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Royalty Pharma PLC (RPRX)
is a Sell
Is Royalty Pharma PLC a Buy, Sell or Hold?
-
The current Royalty Pharma PLC [RPRX] share price is $31.28. The Score for RPRX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
RPRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CREX Stock Price Chart
What is Creative Realities's stock price today?
-
The Creative Realities share price today is $2.04Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CREX is experiencing buying pressure, which is a positive indicator for future bullish movement.
RPRX Stock Price Chart
What is Royalty Pharma PLC's stock price today?
-
The Royalty Pharma PLC share price today is $31.28Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
CREX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.54 | Buy |
Relative Strength Index (14 RSI): | 49.67 | Sell |
Chaikin Money Flow: | 18375 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.84 - 2.08) | Buy |
Bollinger Bands (100): | (2.06 - 3.3) | Sell |
RPRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.29 | Sell |
Relative Strength Index (14 RSI): | 35.96 | Sell |
Chaikin Money Flow: | 3261864 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.92 - 33.72) | Sell |
Bollinger Bands (100): | (26.13 - 32.75) | Buy |
CREX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.98 | Buy |
20-day SMA: | 1.93 | Buy |
50-day SMA: | 2.24 | Sell |
200-day SMA: | 3.59 | Sell |
8-day EMA: | 1.83 | Buy |
20-day EMA: | 1.26 | Buy |
50-day EMA: | 0.66 | Buy |
200-day EMA: | 0.19 | Buy |
RPRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.96 | Sell |
20-day SMA: | 32.63 | Sell |
50-day SMA: | 32.45 | Sell |
200-day SMA: | 28.5 | Buy |
8-day EMA: | 31.79 | Sell |
20-day EMA: | 32.35 | Sell |
50-day EMA: | 31.81 | Sell |
200-day EMA: | 29.5 | Buy |
Creative Realities Earnings Growth & CREX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Royalty Pharma PLC Earnings Growth & RPRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.18 per share, an increase this year of $0.62 per share, and an increase next year of $0.31 per share.
Creative Realities Technical Analysis
Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Royalty Pharma PLC Technical Analysis
Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |